切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2018, Vol. 12 ›› Issue (12) : 659 -664. doi: 10.3877/cma.j.issn.1674-0785.2018.12.002

所属专题: 文献

临床研究

CD8 T淋巴细胞在急性脑梗死后肺炎发病中的作用
郝俊杰1, 杨江胜2, 朱祖福3, 高志强2, 孔玉明4, 李刚1,()   
  1. 1. 200125 同济大学附属上海东方医院神经内科
    3. 214400 东南大学医学院附属江阴市人民医院神经内科
    4. 200090 同济大学附属上海杨浦医院神经内科
  • 收稿日期:2018-01-25 出版日期:2018-06-15
  • 通信作者: 李刚
  • 基金资助:
    上海市浦东新区卫生系统重点学科群建设资助(PWZxq2017-08)

Role of CD8+ T lymphocytes in pathogenesis of pneumonia after acute cerebral infarction

Junjie Hao1, Jiangsheng Yang2, Zufu Zhu3, Zhiqiang Gao2, Yuming Kong4, Gang Li1,()   

  1. 1. Department of Neurology, East Hospital, Tongji University School of Medicine, Shanghai 200125, China
    2. Department of Neurology, Jiangyin People′s Hospital, Southeast University School of Medicine, Jiangsu 214400, China
    4. Department of Neurology, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, China
  • Received:2018-01-25 Published:2018-06-15
  • Corresponding author: Gang Li
  • About author:
    Corresponding author: Li Gang, Email:
引用本文:

郝俊杰, 杨江胜, 朱祖福, 高志强, 孔玉明, 李刚. CD8 T淋巴细胞在急性脑梗死后肺炎发病中的作用[J/OL]. 中华临床医师杂志(电子版), 2018, 12(12): 659-664.

Junjie Hao, Jiangsheng Yang, Zufu Zhu, Zhiqiang Gao, Yuming Kong, Gang Li. Role of CD8+ T lymphocytes in pathogenesis of pneumonia after acute cerebral infarction[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2018, 12(12): 659-664.

目的

采用实验室检测结合临床评估手段,探索CD8 T淋巴细胞在急性脑梗死后肺炎发病中的作用。

方法

收集2014年12至2016年12月在同济大学附属上海东方医院神经内科和东南大学医学院附属江阴市人民医院神经内科住院治疗的急性脑梗死患者60例为研究对象。在脑梗死发病48 h内收集患者静脉血,分离外周血单核细胞,检测细胞表面CD107a,细胞内干扰素γ(IFN-γ)和肿瘤坏死因子α(TNF-α)。依据入组后住院期间是否发生肺炎将60例病例分为发生肺炎组和未发生肺炎组,采用t检验比较肺炎组混合病毒多肽干预及未干预患者、未发生肺炎组混合病毒多肽干预及未干预患者四者之间的外周血单核细胞层细胞表面CD107a脱颗粒、细胞内IFN-γ和TNF-α表达的差异。

结果

在混合病毒多肽刺激CD8 T淋巴细胞后,肺炎组细胞表面CD107a表达低于未发生肺炎组[(10.6±3.7)% vs (15.6±4.3)%)],细胞内IFN-γ表达低于非肺炎组[(15.3±4.3)% vs (20.0±5.1)%],TNF-α表达低于未发生肺炎组[(15.1±4.4)% vs (19.3±4.7)%],差异均具有统计学意义(t=3.192,P=0.004;t=4.127,P<0.001;t=3.621,P<0.001);在未经混合病毒多肽刺激时,肺炎组细胞内IFN-γ表达低于非肺炎组[(3.0±1.2)% vs (3.6±1.7)%)],TNF-α表达低于未发生肺炎组[(3.3±1.4)% vs (4.1±2.1)%],差异也具有统计学意义(t=3.734,P<0.001;t=3.189,P=0.004)。

结论

CD8 T淋巴细胞的细胞毒性作用抑制可能是急性脑梗死患者发生肺炎的重要机制之一。

Objective

To explore the role of CD8+ T lymphocyte in the pathogenesis of pneumonia after acute cerebral infarction by laboratory testing combined with clinical evaluation.

Methods

A total of 60 patients with acute cerebral infarction hospitalized at Department of Neurology of East Hospital Affiliated to Tongji University and Jiangyin People′s Hospital Affiliated to Southeast University from December 2014 to December 2016 were enrolled. Venous blood was collected from patients with cerebral infarction in 48 h of onset, and peripheral blood mononuclear cells were isolated. Cellular CD107a, intracellular IFN-γ and TNF-α were detected. According to whether pneumonia occurred during hospitalization, the 60 cases were divided into a pneumonia group or a non-pneumonia group. The difference in the positive expression of CD107a, IFN-γ and TNF-α was compared among the pneumonia group stimulated with hybrid viral peptides, non-pneumonia group stimulated with hybrid viral peptides, pneumonia group without hybrid viral peptide stimulation and non-pneumonia group without hybrid viral peptide stimulation.

Results

After stimulation with the hybrid viral peptides, CD107a positive expression rates in CD8+ T lymphocytes (10.6±3.7% vs 15.6±4.3%, t=3.192, P=0.004) and intracellular IFN-γ [(15.3±4.3)% vs (20.0±5.1)%, t=4.127, P<0.001] and TNF-α positive expression rates [(15.1±4.4)% vs (19.3±4.7)%, t=3.621, P<0.001] were significantly lower in the pneumonia group than in the non-pneumonia group. Without stimulation with the hybrid viral peptides, intracellular IFN-γ [(3.0±1.2)% vs (3.6±1.7)%, t=3.734, P<0.001] and TNF-α positive expression rates [(3.3±1.4)% vs (4.1±2.1)%, t=3.189, P=0.004] were significantly lower in the pneumonia group than in the non-pneumonia group.

Conclusion

The inhibition of cytotoxicity of CD8+ T lymphocytes is an important mechanism involved in the pathogenesis of pneumonia after acute cerebral infarction.

表1 发生肺炎组与未发生肺炎组患者一般临床资料的比较
表2 发生肺炎组与未发生肺炎组脑梗死患者是否经CEF刺激时CD8 T淋巴细胞的细胞毒性参数比较(±s
1
Ashour W, Al-Anwar AD, Kamel AE, et al. Predictors of early infection in cerebral ischemic stroke [J]. J Med Life, 2016, 9(2): 163-169.
2
Ki-Woong, Nam HM, Kwon JS, et al. Leukoaraiosis is associated with pneumonia after acute ischemic stroke [J]. BMC neurology, 2017, 17(1): 51.
3
Chen LF, Chang CY, Hsu LC, et al. Bacterial pneumonia following acute ischemic stroke [J]. J Chin Med Assoc, 2013, 76(2): 78-82.
4
Finlayson O, Kapral M, Hall R, et al. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke [J]. Neurology, 2011, 77(14): 1338-1345.
5
Westendorp WF, Nederkoorn PJ, Vermeij JD, et al. Post-stroke infection: a systematic review and meta-analysis [J]. BMC Neurol, 2011, 11: 110.
6
Ji R, Shen H, Pan Y, et al. Novel risk score to predict pneumonia after acute ischemic stroke [J]. Stroke, 2013, 44(5): 1303-1309.
7
Hoffmann S, Malzahn U, Harms H, et al. Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic stroke [J]. Stroke, 2012, 43(10): 2617-2623.
8
段茜, 郝俊杰, 李刚. 急性脑卒中后的免疫抑制与肺炎 [J/CD]. 中华脑科疾病与康复杂志(电子版), 2015, 5(6): 423-426.
9
Li G, Wang X, Huang LH, et al. Cytotoxic function of CD8 T lymphocytes isolated from patients with acute severe cerebral infarction: an assessment of stroke-induced immunosuppression [J]. BMC Immunol, 2013, 14: 1.
10
郝俊杰, 郑天衡, 高建, 等. 急性卒中后肺炎的危险因素分析 [J]. 中华临床感染病杂志, 2012, 5(4): 201-204.
11
Kwan J, Pickering RM, Kunkel D, et al. Impact of stroke-associated infection on long-term survival: a cohort study [J]. J Neurol Neurosurg Psychiatry, 2013, 84(3): 297-304.
12
Friedant AJ, Gouse BM, Boehme AK, et al. A simple prediction score for developing a hospital-acquired infection after acute ischemic stroke [J]. J Stroke Cerebrovasc Dis, 2015, 24(3): 680-686.
13
Sui R, Zhang L. Risk factors of stroke-associated pneumonia in Chinese patients [J]. Neurol Res, 2011, 33(5): 508-513.
14
Wartenberg KE, Stoll A, Funk A, et al. Infection after acute ischemic stroke: risk factors, biomarkers, and outcome [J]. Stroke Res Treat, 2011, 2011: 830614.
15
Ye S, Lin SP, Wu K, et al. Serum prealbumin is a predictive biomarker for stroke-associated infection after an ischemic stroke [J]. Int J Neurosci, 2017, 127(7): 601-605.
16
Salat D, Penalba A, García-Berrocoso T, et al. Immunological biomarkers improve the accuracy of clinical risk models of infection in the acute phase of ischemic stroke [J]. Cerebrovasc Dis, 2013, 35(3): 220-227.
17
Dirnagl U, Klehmet J, Braun JS, et al. Stroke-induced immunodepression: experimental evidence and clinical relevance [J]. Stroke, 2007, 38(2 Suppl): 770-773.
18
Prass K, Meisel C, Höflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation [J]. J Exp Med, 2003, 198(5): 725-736.
19
Folyovich A, Biró E, Orbán C, et al. Relevance of novel inflammatory markers in stroke-induced immunosuppression [J]. BMC Neurol, 2014, 14: 41.
20
Emsley HC, Hopkins SJ. Post-stroke immunodepression and infection: an emerging concept [J]. Infect Disord Drug Targets, 2010, 10(2): 91-97.
21
Harms H, Reimnitz P, Bohner G, et al. Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection [J]. Cerebrovasc Dis, 2011, 32(6): 552-560.
22
Berg RE, Forman J. The role of CD8 T cells in innate immunity and in antigen non-specific protection [J]. Curr Opin Immunol, 2006, 18(3): 338-343.
23
Masopust D, Vezys V, Wherry EJ, et al. A brief history of CD8 T cells [J]. Eur J Immunol, 2007, 37 Suppl 1: S103-S110.
24
Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation [J]. Nat Med, 2011, 17(7): 796-808.
25
Li P, Gan Y, Sun BL, et al. Adoptive regulatory T-cell therapy protects against cerebral ischemia [J]. Ann Neurol, 2013, 74(3): 458-471.
[1] 李世杰, 申传安. 烧伤合并吸入性损伤患者呼吸机相关肺炎的研究现状[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 351-355.
[2] 张胜伟, 孟召路, 热汗古丽·吾休尔, 万世森, 闫鹏, 阳乔. 肺炎支原体诱发反应性感染性皮疹黏膜疹一例[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 309-313.
[3] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[4] 胡菊英, 李银华, 洪兰, 王宏勇, 丁先军, 李承美, 谭心海. 儿童感染大叶性肺炎与支气管肺炎临床特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 813-816.
[5] 晏彦, 杨军, 周凤兰, 孙登昆, 陈玉. 哌拉西林他唑巴坦和哌拉西林舒巴坦治疗细菌性肺炎的倾向性匹配分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 817-819.
[6] 于燕兴, 梅喜庆, 刘凤娟, 于梓薇, 许亚慧, 徐飞. 高通量测序重症肺炎肺泡灌洗液病原体的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 785-788.
[7] 刘雯, 赵明栋, 夏伟, 潘以雄. 不同剂量比阿培南治疗重症肺炎的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 789-792.
[8] 刘春军, 严方方, 王宝锋, 常婷婷, 郭红红, 李志强. 替加环素联合人免疫球蛋白治疗XDRAB致VAP 的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 797-800.
[9] 孙顗淼, 张颖. 糖尿病患者急性脑梗死取栓术后发生对比剂肾病的影响因素及预测模型建立[J/OL]. 中华肾病研究电子杂志, 2024, 13(04): 188-194.
[10] 谢井伟, 王森, 王非, 郭永坤. STA-MCA血管搭桥术治疗烟雾病[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 318-320.
[11] 李刚, 潘晓帆, 田雪, 刘路路. CT灌注成像参数及血栓弹力图对急性前循环脑梗死早期神经功能恶化的预测价值分析[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 226-232.
[12] 杨东星, 沈鹏, 赵慧颖. 免疫球蛋白联合依库珠单抗治疗GBS 并发重度ARDS 患者一例[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 404-408.
[13] 段伟, 刘飞, 许光源, 程宇豪, 陈星. 食管癌调强放疗计划剂量学参数差异对放射性肺炎发生及严重程度的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 320-324.
[14] 克地尔牙·马合木提, 胡波, 杨琼, 闫素, 胡岚卿, 高沛沛, 姚恩生. 依达拉奉右莰醇对急性脑梗死后认知功能障碍的疗效观察[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 459-466.
[15] 刘焕亮, 崔慧娟, 曹慧, 付源. 颈动脉狭窄处剪切率对高同型半胱氨酸血症患者脑梗死的预测价值[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 317-322.
阅读次数
全文


摘要